Strong evidence indicates that AID might contribute to the development of colitis-associated and inflammatory bowel disease (IBD)-associated colorectal cancers by linking colonic inflammation to an enhanced genetic susceptibility to oncogenic mutagenesis [54–56]. This evidence concerns the gene AICDA and colitis.